| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |